Acasti Pharma reported $-4.76M in Sales Revenues for its fiscal quarter ending in December of 2024.





Sales Change Date
Acasti Pharma USD -4.76M 4.76M Dec/2024
Addus HomeCare USD 377.41M 13.81M Jun/2026
Amarin USD 49.22M 451K Dec/2025
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Option Care Health USD 1.44B 90M Jun/2026
Organigram Holdings CAD 59.79M 3.74M Mar/2026
Tilray USD 217.51M 74.75M Dec/2025